SELÇUK MISTIK, Ayşegül ULUDAĞ, DEMET KARTAL, Salih Levent ÇINAR

Bacterial Skin Infections: Epidemiology and Latest Research

Cilt enfeksiyonları tüm dünyada yaygın olarak görülmektedir. Cilt enfeksiyonlarının prevalansı sırasıyla: piyoderma (prevalans aralığı %0,2-35, Sahra Altı Afrikada %6,9-35), tinea kapitis (%1-19,7), skabies (%0,2-24, Sahra Altı Afrikada %1,3- 17), viral cilt sorunları (%0,4-9, esas olarak molluskum kontagiozum), pedikülozis kapitis (%0-57) olarak bildirilmiştir. Bakteriyel cilt enfeksiyonları en sık görülen cilt enfeksiyonu tipidir. En sık görülen bakteriyel cilt enfeksiyonları impetigo, follikülit, furonkülozis ve abse, selülit, kızıl, erizipel, eritrazma, nekrotizan fasiit ve bazı diğer enfeksiyonlardır. Bunlara ek olarak, ektima, karbonkül ve mikobakterium cilt enfeksiyonları da bu derlemede tartışılmıştır. En son araştırmalar bize bakteriyel cilt enfeksiyonlarının etiyoloji ve tedavisinde yakın zamanda olan değişikliklerin bilgisini vermektedir. İmpetigoda metisiline dirençli S. aureus (MRSA) artışı, yakın zamanda bize bunların tedavisinde daha dikkatli olmamız gerektiğini göstermiştir. Ayrıca, anne kaynaklı çinko desteği verilmesi gibi cilt enfeksiyonlarının önlenmesinde yeni öneriler bulunmaktadır.

Bakteriyel Cilt Enfeksiyonları: Epidemiyoloji ve En Son Araştırmalar

Skin infections are very common throughout the world. The prevalence of skin infections has been reported as follows: pyoderma (prevalence range 0.2-35%, 6.9- 35% in Sub-Saharan Africa), tinea capitis (1-19.7%), scabies (0.2-24%, 1.3-17% in Sub-Saharan Africa), viral skin disorders (0.4-9%, mainly molluscum contagiosum), pediculosis capitis (0-57%). Bacterial skin infections are the most common type of skin infections. The most common bacterial skin infections are reported as impetigo, folliculitis, furunculosis and abscesses, cellulitis, scarlet fever, erysipelas, erythrasma, necrotizing fasciitis and some others. In addition to these, ecthyma, carbunculosis, and mycobacterium skin infections are discussed in this review. The latest research gives us the information on the recent change in the bacterial etiology and treatment of bacterial skin infections. The increase in methicillin-resistant S. aureus (MRSA) in impetigo has recently shown us the necessity of being more careful in regard to its treatment. There are also new measures to prevent skin infections, such as the use of maternal zinc supplementation.

___

1 World Health Organization: Epidemiology and Management of Common Skin Diseases in Developing Countries Geneva, World Health Organization 2005.
2 dos Santos MM, Amaral S, Harmen SP, Joseph HM, Fernandes JL. Counahan ML. The prevalence of common skin infections in four districts in Timor-Leste: a cross sectional survey. BMC Infectious Diseases. 2010;10(10):61.
3 Mohammed Amin RSA. Infectious skin diseases in children in general practice, EUR Medical dissertation, PhD Thesis, Erasmus University, Rotterdam, 14 Feb. 2007.
4 Krowchuk DP, Bradham DD, Fleischer AB Jr. Dermatologic services provided to children and adolescents by primary care and other physicians in the United States. Pediatric Dermatology. 1994;11(3):199‑203.
5 Hayden GF. Skin diseases encountered in a pediatric clinic: A one year prospective study. American Journal of Diseases of Children. 1985;139(1):36‑38.
6 Tunnessen WW. A survey of skin disorders seen in pediatric general and dermatology Clinics. Pediatric Dermatology. 1984;1(3):219‑22.
7Andrews RM, McCarthy J, Carapetis JR, Currie BJ. Skin disorders, including pyoderma, scabies, and tinea infections. Pediatric Clinics of North America. 2009;56(6):1421-40.
8 http://www.dermnetnz.org/bacterial/ (accessed date- 20.August.2014)
9.https://www.clinicalkey.com/topics/pediatrics/impetigo. html (accessed date-20.August.2014)
10 Catherine M, Julie P. Bacterial Diseases. In: Bolognia JL, ed. Bolognia: Dermatology. 2nd ed. India: Mosby Elsevier; 2008:1512.
11 Garfunkel LC, Kaczorowski J, Christy C eds. Pediatric Clinical Advisor. 2nd edition. St. Louis, Mo, USA: Mosby Elsevier, Section12, 2007.
12 Habif TP. Vascular tumors and malformations. In: Habif TP, ed. Clinical Dermatology. 5th ed. St. Louis, Mo: Mosby Elsevier, Chap 12, 2009.
13 Bennett JE. Bacterial Skin Infections. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA: Elsevier Churchill-Livingstone; Chap 50, 2009.
14 Axe JM, Axe MJ. High school wrestling tournament decision making. Delawere Medical Journal. 2014;86(6):173-9.
15 Shim J, Lanier J, Qui MK. Clinical Inquiry: What is the best treatment for impetigo? Journal of Family Practice. 2014;63(6):333-5.
16 Shigemura T, Yamazaki T, Shiohara M, Kobayashi N, Naganuma K, Koike K, et al. Clinical course in a patient with neutrophil-specific granule deficiency and rapid detection of neutrophil granules as a screening test. Journal of Clinical Immunology. 2014;34(7):780-3.
17 McCollum AM, Holman RC, Hughes CM, Mehal JM, Folkema AM, Redd JT, et al. Molluscum contagiosum in a pediatric American Indian population: incidence and risk factors. PLoS One. 2014;l9(7):1-6.
18 Hayashida S, Furusho N, Uchi H, Miyazaki S, Eiraku K, Gondo C, et al. Are lifetime prevalence of impetigo, molluscum and herpes infection really increased in children having atopic dermatitis? Journal Dermatological Science. 2010;60(3):173-8.
19 Nasr SH, Fidler ME, Valeri AM, Cornell LD, Sethi S, Zoller A et al. Postinfectious glomerulonephritis in the elderly. Journal of American Society of Nephrology. 2011;22(1):187-95.
20 Berrios RL, Arbiser JL. Effectiveness of gentian violet and similar products commonly used to treat pyodermas, Dermatologic Clinics. 2011;29(1):69-73
21 Dalager-Pedersen M, Sogaard M, Schonheyder HC. Staphylococcus aureus skin and soft tissue infections in primary healthcare in Denmark: a 12-year populationbased study. European Journal of Clinical Microbiology and Infectious Diseases. 2011;30(8):951-6.
22 Hisata K, Ito T, Matsunaga N, Komatsu M, Jin J, Li S, et al. Dissemination of multiple MRSA clones among community-associated methicillin-resistant Staphylococcus aureus infections from Japanese children with impetigo. Journal of Infection and Chemotherapy. 2011;17(5):609-21
23 Rortveit S, Skutlaberg DH, Langeland N, Rortveit G. Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristics. The Journal of Antimicrobial Chemotheraphy. 2011;66(6):1360-4.
24 Iovino SM, Krantz KD, Blanco DM, Fernández JA, Ocampo N, Najafi A, et al. NVC-422 topical gel for the treatment of impetigo. International Journal of Clinical and Experimental Pathology. 2011;4(6):587-95.
25 Darmstadt GL, Osendarp SJ, Ahmed S, Feldman C, Van Raaij JM, Baqui AH, et al. Effect of antenatal zinc supplementation on impetigo in infants in Bangladesh. Pediatric Infectious Disease Journal. 2012;31(4):407-9.
26 Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LW, Morris AD, Butler CC, et al. Interventions for impetigo. Cochrane Database Systematic Review. 2012;1(1).
27 Rijnders MI, Wolffs PF, Hopstaken RM, den Heyer M, Bruggeman CA, Stobberingh EE. Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands" Journal of Antimicrobial Chemotherapy. 2012;67(5):1176- 80.
28 Bolaji RS, Dabade TS, Gustafson CJ, Davis SA, Krowchuk DP, Feldman SR. Treatment of impetigo: oral antibiotics most commonly prescribed. Journal of Drugs Dermatology. 2012;11(4):489-94.
29 Gropper S, Albareda N, Chelius K, Kruger D, Mitha I, Vahed Y. Ozenoxacin 1% cream in the treatment of impetigo: a multicenter, randomized, placebo- and retapamulin-controlled clinical trial", Future Microbiology, 2014;9(2):1013-23.
30 Sonthalia S, Singal A, Khurana R. Ecthyma, Indian Pediatric. 2014;51(6):510-1.
31. Song WK, Kim YC, Park HJ, Cinn YW. Ecthyma gangrenosum without bacteraemia in a leukaemic patient. Clinical Experimental Dermatology. 2001;26(5):39597.
32 Fine JD, Miller JA, Harrist TJ, Haynes HA. Cutaneous lesions in disseminated candidiasis mimicking ecthyma gangrenosum. American Journal of Medicine. 1981;70:(5);11335.
33 Altemeier WA, Todd JC, Inge WW. Gram-negative septicemia: a growing threat. Annuals of Surgery.1967;166(4):53042.
34 Huminer D, Siegman-Igra Y, Morduchowicz G, Pitlik SD. Ecthyma gangrenosum without bacteremia: report of six cases and review of the literature. Archieve Internal Medicine. 1987;147(2):299301.
35 Bodey GP, Bolivar R, Fainstein V, Jadeja L. Infections caused by Pseudomonas aeruginosa. Review Infectious Disease. 1983;5(2);279313.
36.http://www.cfsph.iastate.edu/Factsheets/pdfs/contagiou s_ecthyma.pdf (access date:07.Dec.2014)
37 Cohen N, Capua T, Bilavsky E, Dias-Polak H, Levin D, Grisaru-Soen G. Ecthyma gangrenosum skin lesions in previously healthy children. Acta Paediatrica. 2014 (Epub ahead of print).
38 Vaiman M, Lazarovitch T, Heller L, Lotan G. Ecthyma gangrenosum and ecthyma-like lesions: review article. European Journal of Clinical Microbiology and Infectious Disease. 2014 (Epub ahead of print)
39 Stollery N. Skin infections. Practitioner. 2014;258(1770); 32-3.
40 http://emedicine.medscape.com/article/1070456- overview#a0199. ( access date:07.Dec.2014)
41 Artzi O, Sinai M, Solomon M, Schwartz E. Recurrent furunculosis in returning travelers: newly defined entity, Journal of Travel Medicine. 2015;22(1):21-5.
42 Davido B, Dinh A, Salomon J, Roux AL, GossetWoimant M, Pierre I, et al. Recurrent furunculosis: efficacy of the CMC regimen--skin disinfection (chlorhexidine), local nasal antibiotic (mupirocin), and systemic antibiotic (clindamycin). Scandinavian Journal of Infectious Disease. 2013;45(3):837-41.
43 Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. New England Journal of Medicine. 1996;34(334):240-5.
44 Swartz MN. Clinical practice, Cellulitis. New England Journal Medicine. 2004;350(9):904-12.
45 Caetano M, Amorin I. Erisipela. Acta Medica Portuaguesa. 2005;18(5):385-93.
46 Dong SL, Kelly KD, Oland RC, Holroyd BR, Rowe BH. ED management of cellulitis: a review of five urban centers. American Journal of Emergency Medicine. 2001;19(7);35-40.
47 Stevenson A, Hider P, Than M. The utility of blood cultures in the management of non-facial cellulitis appears to be low. New Zealand Medicine Journal. 2001;11(118):1351.
48 Gunderson CG, Martinello RA. A systematic review of bacteremias in cellulitis and erysipelas. Journal of Infection. 2011;64(2);148-55.
49 Hakkarainen TW, Kopari NM, Pham TN, Evans HL. Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes", Current Problems in Surgery. 2014;51(8);344-62.
50 Ford LM, Waksman J. Necrotizing fasciitis during primary varicella. Pediatrics. 2000; 105(6);137275.
51 Sturgeon JP, Segal L, Verma A. Going out on a limb: do not delay diagnosis of necrotizing fasciitis in Varicella infection. Pediatr Emerg Care. 2014. (Epub ahead of print) 52 Shaw JJ, Psoinos C, Emhoff TA, Shah SA, Santry HP. Not just full of hot air: hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections. Surgical Infectious. 2014;15(3):328-35.
53 Mondello P, Pitini V, Arrigo C, Mondello S, Mian M, Altavilla G. Necrotizing fasciitis as a rare complication of osteonecrosis of the jaw in a patient with multiple myeloma treated with lenalidomide: case report and review of the literature. Springerplus. 2014;5(3):123.
54 Badri T, Sliti N, Benmously R, Hammami H, Ben Jennet S, Mokhtar I, et al. Erythrasma: study of 16 cases. Tunis Medicine. 2014;92(4):245-8.
55 Inci M, Serarslan G, Ozer B, Inan MU, Evirgen O, Erkaslan Alagoz G, et al. The prevalence of interdigital erythrasma in southern region of Turkey. Journal of European Academic Dermatology and Venereology. 2012;26(11):1372-6.
56 Holdiness MR. Management of cutaneous erythrasma, Drugs. 2002;62(8);1131-41.
57 Avci O, Tanyildizi T, Kusku E. A comparison between the effectiveness of erythromycin, single-dose clarithromycin and topical fusidic acid in the treatment of erythrasma, Journal of Dermatolog Treatment. 2013; 24(1):70-4.
58 Kerr JH, Barrett TL. Atypical Mycobacterial Diseases. Brigadier General Russ Zajtchuk, ed. Textbook of Military Medicine and Military Dermatology. Chapter 16. 1st edition. Washington, USA: Office of The Surgeon General at TMM Publications:1994;391-422.
59 Hautmann G, Lotti T. Atypical mycobacterial infections: a difficult and emerging group of infectious dermatoses. International Journal of Dermatology. 1993;32(7):499-501.
60 Palenque E. Skin disease and nontuberculous atypical mycobacteria. International Journal of Dermatology. 2000;39(9):659- 66.
61 Sungkanuparph S, Sathapatayavongs B, Pracharktam R. Infections with rapidly owing mycobacteria: report of 20 cases. International Journal of Infectious Disease. 2003;7(3):198205.
62 Bartralot R, Pujol RM, Garcia-Patos V, Sitjas D, Martín-Casabona N, Coll P. Cutaneous infections due to nontuberculous mycobacteria: histopathological review of 28 cases. Comparative study between lesions observed in immunosuppressed patient and normal host. Journal of Cutaneous Pathology. 2000;27(3);1249.
63 Uslan DZ, Kowalski TJ, Wengenack NL, Virk A, Wilson JW. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Archive of Dermatology. 2006;142(3):1287-92.
64 Escalonilla P, Esteban J, Soriano ML et al. Cutaneous manifestations of infection by nontuberculous mycobacteria. Clinical Experimental Dermatology. 1998; 23(5):214-21.
65 El-Khalawany MA. Atypical mycobacterial cutaneous infections in Egyptians: a clinicopathological study. Journal of Dermatology. 2014;41(4):303-10.
66 Alcaide F, Esteban J. Cutaneous and soft skin infections due to non-tuberculous mycobacteria. Enfermedades Infecciosas y Microbiología Clínica. 2010;28(1):46-50.
67 Streit M, Bregenzer T, Heinzer I. Cutaneous infections due to atypical mycobacteria. Hautarzt. 2008;59(1):59-70.
68 Al-Anazi KA, Al-Jasser AM, Al-Anazi WK. Infections caused by Non-Tuberculous Mycobacteria in recipients of hematopoietic stem cell transplantation. Frontiers Oncology; 2014;10(4):311.
69 Luz KG, Britto MH, Farias DC, Almeida MV, Figueirêdo NM, Silva Pde M. Mycobacterium fortuitumrelated lymphadenitis associated with the varicella-zoster virus. Revista da Sociedade Brasileira de Medicina.vol. 2014;47(1):119-21.